27 July 2021

Coming up: Delta crisis, rapid testing, ATAGI confusion

Clinical

ATAGI is now making special recommendations for Sydney. People of all ages are now encouraged to have AZ if they can’t get access to the Pfizer jab.

Should we be shortening or lengthening the intervals for covid jabs? Understand the risk/benefit considerations for each age group so that you can more effectively explain these things to your patients.

During the webcast on 3 August, A/Prof Nicholas Wood, NCIRS Associate Director, will also provide an update on the Delta variant and what it means for us while we wait for the national vaccination program to catch up with this tricky new variant. Which vaccines currently work and by how much against this and other variants.

The question of vaccinating children is now emerging and this is likely to be a thorny issue. Current available data concerning safety and effectiveness of the covid vaccines for children and pregnant women will be explained.

REGISTER HERE

Attendees will be eligible for:

RACGP: 5 CPD activity points

ACRRM: 2.5 hours under the educational activities category

Pharmacists: Currently Seeking Accreditation

Don’t miss out, REGISTER NOW.

Topics include:

The Latest COVID Update

A/Prof Nicholas Wood – Associate Director, National Centre for Immunisation Research and Surveillance

Tailoring Antidepressant Therapy to Clinical Profile

Clinical A/Prof David Horgan – Psychiatrist; Honorary Psychiatrist, Royal Melbourne Hospital; Founder, Australian Suicide Prevention Foundation; Clinical Associate Professor, Department of Psychiatry, University of Melbourne

Depressive illness varies in features and as such, therapeutic agents should be selected on the likely clinical efficacy for a given individual. The side effect profile must also be considered. Both should be discussed with patient. This has been emphasised in the new mood disorders guidelines.

Beyond Mood Control: The Importance of Treating Residual Symptoms

Clinical A/Prof David Horgan – Psychiatrist; Honorary Psychiatrist, Royal Melbourne Hospital; Founder, Australian Suicide Prevention Foundation; Clinical Associate Professor, Department of Psychiatry, University of Melbourne

Management of depression extends beyond relief of the basic symptoms. Quality of life and relationships, employment and self-perception require functional wellness. Medication choices, counselling and regular follow-up with careful monitoring are needed.

Modern Management of Schizophrenia in Primary Care

Prof Malcolm Hopwood – Psychiatrist; Director of the Professorial Psychiatry Unit, University of Melbourne, Albert Road Clinic

There is a wide and increasing range of antipsychotic agents and the choices made need to be integrated into a shared-care model. Conveying an understanding of side effects is very important. Management pathways will involve a range of expertise with the GP having a crucial role in diagnosis and follow up.

Understanding Antipsychotic Medications and Metabolic Side Effects

Prof Malcolm Hopwood – Psychiatrist; Director of the Professorial Psychiatry Unit, University of Melbourne, Albert Road Clinic

Metabolic dysregulation is a potential side effect of antipsychotics. This includes changes in cholesterol, triglycerides, BSL and BMI. These changes can cause or exacerbate comorbidities. This is a complex area and predictors are poorly understood. Weight gain is a major problem for compliance. 

PLEASE NOTE: Due to the high levels of traffic we experience and the new log in process to our website, please make sure you log in to the website 15 minutes prior to the start of the webcast to ensure that your viewing is not disrupted.

Date:

Tuesday 3 August

Time:

7:00pm – 9:30pm AEST (NSW, VIC, TAS, ACT, QLD)
6:30pm – 9:00pm ACDT (SA, NT)
5:00pm – 7:30pm AWST (WA)

COVID-19 live update